As of Sep 23
| +0.06 / +5.31%|
The 1 analysts offering 12-month price forecasts for CASI Pharmaceuticals Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +152.10% increase from the last price of 1.19.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.